GT Biopharma (OXIA.F) Q4 2025 Earnings

Nov 14Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.6
-1.16
-0.73
-0.29

Details

Expected EPS
-0.326914
Actual EPS
-0.7140489999999999
Surprise EPS
-0.39
Surprise Percent
-118.42%

Description

⁨GT Biopharma⁩ (⁦OXIA.F⁩) has reported earnings of ⁦-0.7140489999999999⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts